肝肾综合征肾血流量下降机制的研究(3)
 |
| 第1页 |
参见附件(3617KB，4页)。
[11] Salerno F，Gerbes A，Gines P，et al. Diagnosis， prevention and treatment of hepatorenal syndrome in cirrhosis[J]. Gut，2007，56(9)：1310-1318.
[12] Yang YY，Lin HC，Huang YT，et al. Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen[J]. J Hepatol，2005，42(5)： 652-658.
[13] Hirokawa K，Shaughnessy K，Moore K，et al. Induction of nitric oxide synthase in cultured vascular smooth muscle cells： the role of cyclic AMP[J]. Br J Pharmacol，1994， 112(2)： 396-402.
[14] Bankir L，Ahloulay M，Devreotes PN，et al. Extracellular cAMP inhibits proximal reabsorption： are plasma membrane cAMP receptors involved? [J]. Am J Physiol， 2002， 282(3)： F376-392.
[15] Glab M， Lojek A， Wrzosek A， et al. Endothelial mitochondria as a possible target for potassium channel modulators[J]. Pharmacol Rep， 2006， 58 Suppl： 89-95.
[16] Teramoto N.Pharmacological profile of U-37883A，a channel blocker of smooth muscle-type ATP-sensitive K Channels[J]. Cardiovasc Drug Rev， 2006， 24(1)： 25-32.
[17] Barriere E，Tazi KA，Pessione F，et al. Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis[J]. J Hepatol，2001， 35(3)： 350-357.
[18] Yang YY，Lin HC，Huang YT，et al. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis[J]. Liver Int， 2007， 27(8)： 1045-1055.
[19] Trebicka J，Leifeld L，Hennenberg M，et al. Hemodynamic effects of urotensin Ⅱ and its specific receptor antagonist palosuran in cirrhotic rats [J] ......
您现在查看是摘要介绍页，详见PDF附件(3617KB，4页)。